Bruker (BRKR) Peer Comparison

$61.35

$3.29 (5.67%)

As on 06-Nov-2026 12:36EST

Market cap

$8,695 Mln

Revenue (TTM)

$3,500 Mln

P/E Ratio

--

P/B Ratio

4

Div. Yield

0.3 %

Edit

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Market cap ($ Mln)	8,695	13,022	12,656	11,234	10,259
Revenue ($ Mln)	3,500	690	1,560	806	6,636
Net Profit ($ Mln)	-71.20	-169.80	157.02	-11.80	337.20
Net Margin (%)	-2.03	-24.60	10.06	-1.47	5.08
RoE (%)	-3.21	-24.46	10.27	-0.56	5.90
Price to Earnings	--	--	80.88	--	31.54
Price-To-Book	3.97	18.16	8.03	5.37	1.81

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Operating Revenue	3,499.60	690.33	1,560.33	805.61	6,635.60
Cost of Revenue	1,865.70	130.29	499.55	394.34	4,539.20
Gross Profit	1,577.70	393.22	942.44	347.62	2,139.40
Operating Expenses	1,507.40	623.34	871.54	392.34	1,593.70
Operating Profit (EBIT)	126.50	-63.30	189.25	18.93	502.70
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-28.10	-174.52	207.82	8.23	315.50
Provision for Tax	40.40	-4.72	50.81	20.03	-21.70
Profit after Tax (Net Income)	-71.20	-169.80	157.02	-11.80	337.20
Minority Interest	-6.70	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	47.34	0.00	0.00

Liabilities ($ Mln)

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Shareholder's Funds	2,400.20	717.27	1,583.51	2,091.74	5,835.90
Minority Interest	-6.70	0.00	0.00	0.00	0.00
Non-Current Liabilities	2,393.60	135.53	207.78	708.99	4,425.10
Current Liabilities	1,204.70	126.73	233.81	125.69	1,369.00
Total Liabilities	6,241.40	893.49	1,826.52	2,949.70	11,794.70

Assets ($ Mln)

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Non-Current Assets	3,827.90	399.88	648.47	1,684.42	9,037.40
Current Assets	2,225.00	579.65	1,376.63	1,241.98	2,592.60
Total Assets	6,241.40	893.49	1,826.52	2,949.70	11,794.70
Total Debt*	1,915.70	101.98	209.39	692.24	3,683.80
Net Current Assets	1,020.30	452.92	0.00	0.00	1,223.60

Cashflow ($ Mln)

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Cash From Operating Activities	134.10	-46.34	238.66	117.42	623.80
Cash Flow from Investing Activities	-196.50	-77.61	-404.59	-298.47	-130.50
Cash from Financing Activities	135.10	11.89	26.53	-15.21	-409.40
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
ROCE (%)	-0.20	-22.53	11.76	1.79	-5.43
ROE (%)	-3.21	-24.46	10.27	-0.56	5.90
ROA (%)	-0.95	-15.48	5.91	-0.33	2.57
EBIT Margin (%)	0.50	-24.51	13.40	4.20	7.39
Net Margin (%)	-2.03	-24.60	10.06	-1.47	5.08
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Revenue Growth (%)	1.65	46.94	16.98	13.80	0.92
EBIT Growth (%)	-90.88	-106.70	11.72	29.47	106.97
Net Profit Growth (%)	-189.45	-93.80	-4.27	-779.17	510.22
EPS Growth (%)	-189.62	-90.00	-4.95	-910.66	507.22
Book Value Growth (%)	32.61	-12.58	15.61	0.35	4.89

Valuation Ratios

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Price / Earnings	-835.38	-34.59	68.93	189.42	-14.68
Price / Book Value	2.92	9.90	8.58	4.40	1.40
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	29.51	-43.50	53.25	50.32	81.94
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Debt to Equity	0.76	0.00	0.00	0.00	0.63
Short term debt to equity ratio	0.04	0.00	0.01	0.01	0.01
Current Ratio	1.85	4.57	5.89	9.88	1.89
Quick Ratio	0.92	4.09	3.92	8.43	1.27
Interest Coverage	0.54	-35.23	165.16	1.24	2.81

Operating Efficiency Ratios

	Bruker (BRKR)	Glaukos Corp (GKOS)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)
Debtors to sales (%)	25.01	21.73	12.51	18.77	16.92
Asset Turnover	0.47	0.63	0.59	0.22	0.51
Receivable days	76.38	60.95	46.54	72.41	58.79
Inventory Days	212.45	193.84	331.92	146.53	64.13
Payable days	44.21	60.19	26.16	29.05	58.13
Cash Conversion Cycle	244.62	194.60	352.30	189.88	64.79

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly